Business
Why the Orthocell (ASX:OCC) share price has popped 6% today
The Orthocell Ltd (ASX: OCC) share price is surging higher today. This comes after the biotechnology company received Australian market approval for its CelGro product. CelGro is a collagen scaffold that supports tissue reconstruction and repair, with a wide range of uses in orthopaedics, general, gynaecology and ENT surgeries.
At the time of writing, the Orthocell share price is up 6% to 43.5 cents.
What’s moving the Orthocell share price?
Investors appear to be pleased with the latest news from the company, pushing the Orthocell share price higher.
With the latest approval, Orthocell can now begin to supply and market CelGro in dental bone and tissue regeneration procedures. According to the company, the CelGro device provides…
-
Noosa News20 hours agoLaidley e-scooter death: Tragic new details after Summah Richards killed in freak accident
-
General21 hours agoMinjee Lee rallies after third-round meltdown to share fifth place at LA Championship
-
General15 hours agoUkraine says Russia has ramped up attacks despite ‘Easter truce’
-
General14 hours agoPope Francis appears Easter Sunday to deliver blessing as recovery continues